Results

Total Results: 628 records

Showing results for "prescribing".

  1. effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
    January 01, 2012 - Truvada (emtricitabine/tenofovir disoproxil fumarate) tablets prescribing information. … DIFICID (fidaxomicin) tablets, for oral use prescribing information. [internet].
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_consumer.pdf
    November 01, 2016 - Noninvasive Treatments for Low Back Pain: A Summary of the Research for Adults Noninvasive Treatments for Low Back Pain A Summary of the Research for Adults e DRAFT: CONFIDENTIAL - For review only, not for dissemination - Task 3.7c- LowBackPain_consumer - Last mod on: 15-Nov-2016, 11:04 Archived: This report i…
  3. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-library-asthma.pdf
    April 01, 2019 - Standardized Library of Asthma Outcome Measures Research White Paper Standardized Library of Asthma Outcome Measures Research White Paper Standardized Library of Asthma Outcome Measures Prepared for: Agency for Healthcare Research and Quality Center for Outcomes and Ev…
  4. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - Victoza (liraglutide (RDNA origin) injection) injection, solution prescribing information.
  5. effectivehealthcare.ahrq.gov/sites/default/files/interventions-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - be educated about their medications, and potential to lessen the burden of care that rests on the prescribing
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
    April 01, 2010 - Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of AHRQ’s Effective Health Care Program. It is a collaborative network of research centers that support the rapid…
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
    March 01, 2010 - MEDICAL MANAGEMENT OF CONGESTIVE HEART FAILURE AND THE EFFECTIVENESS OF ISOSORBIDE DINITRATE AND HYDRALAZINE The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of AHRQ’s Effective Health Care Program. It is a collaborative network of research centers that support the rapi…
  8. effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
    January 01, 2010 - 45 Abstract Characterization of exposure is a central issue in the analysis of observational data; however, no “one size fits all” solution exists for exposure measurement. In this chapter, we discuss potential exposure measurement approaches for observational comparative effectiveness research (CER). First, it is …
  9. effectivehealthcare.ahrq.gov/sites/default/files/ch_1-user-guide-to-ocer_130129.pdf
    August 13, 2012 - 7 Abstract The steps involved in the process of developing research questions and study objectives for conducting observational comparative effectiveness research (CER) are described in this chapter. It is important to begin with identifying decisions under consideration, determining who the decisionmakers and sta…
  10. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
    September 01, 2009 - Layout 1 Background Over 28 million Americans have some form of cardiovascular disease (CVD), which causes more deaths than cancer, diabetes, accidents, and chronic lung diseases combined. Estimated direct medical expenditures and lost productivity from CVD amounted to $431.8 billion in the United States in 2007. …
  11. effectivehealthcare.ahrq.gov/sites/default/files/methodsguidenorris_060420101.pdf
    June 01, 2010 - studies, particularly the recognition that intended effects are more likely to be biased by preferential prescribing
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-observational-studies_methods.pdf
    June 01, 2010 - studies, particularly the recognition that intended effects are more likely to be biased by preferential prescribing
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/acute-pain-protocol-amended.pdf
    June 10, 2018 - Therefore, caution is necessary when prescribing pharmacologic pain treatment, especially in certain
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
    December 15, 2010 - Evidence Report on the Source: www.effectivehealthcare.ahrq.gov Published Online: April 28, 2011 Page 1 of 26 Evidence-based Practice Center Systematic Review Protocol Project Title: Comparative Effectiveness of Dietary Supplement Versus No Dietary Supplement Use in Adults Taking Cardiovascular D…
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
    September 01, 2014 - Published Online: February 11, 2014 35 Commentator Section Comments Response individual before of prescribing
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/allergy-seasonal_research-protocol.pdf
    March 08, 2012 - Atrovent® (ipratropium bromide) nasal spray 0.06%: prescribing information. … docBase=renetnt&folderPath=/Prescribing+Infor mation/PIs/Atrovent+Nasal+06/Atrovent006.pdf.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/major-depressive-disorder-disposition-160504.pdf
    December 08, 2015 - John's wort are generally not included in drug-drug interaction checking software including electronic prescribing … While that dosage is within the normal prescribing range, we understand how the upper limit could result … While that dosage is within the normal prescribing range, we understand how the upper limit could
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_disposition-comments.pdf
    February 25, 2014 - As stated in the approved Prescribing Information, the initial dose of CZP is 400 mg subcutaneously … also suggest including in the Executive Summary in Table A, page ES-2, the indicated dosage from the Prescribing … comparative effectiveness review be strengthened by summarizing outcome findings relevant from the prescribing … Recommendation & Justification: Please consider adjusting the remission rate numbers to those from the current prescribing
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
    March 01, 2019 - In 2015, this list recommended that clinicians avoid prescribing selective serotonin reuptake inhibitors
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
    June 01, 2022 - What are the effects of prescribing opioid therapy versus not prescribing opioid therapy for acute treatment

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: